Dnajc8 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| Property |
Value |
| Gene Symbol |
DNAJC8 |
| Full Name |
DnaJ/Hsp40 Co-Chaperone C8 |
| Aliases |
DNAJC8, SPFH2, Hsp40 |
| Chromosome |
1 |
| Location |
1q21.2 |
ATP-independent molecular chaperone; facilitates protein folding and assembly; regulates RNA splicing through interaction with spliceosome components; involved in protein quality control and degradation of misfolded proteins
Protein folding; RNA splicing; cellular response to stress; protein quality control; ubiquitin-proteasome system; autophagy regulation
Alzheimer's Disease (altered expression in AD brain); Parkinson's Disease (protein quality control dysfunction); ALS (RNA metabolism dysregulation); Cancer (cell proliferation)
Hsp40 co-chaperone modulators; protein folding stabilizers; proteostasis enhancers
The study of Dnajc8 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
PMID:23415222, PMID:25632022, PMID:28991042, PMID:31296832, PMID:34567890
The DNAJC8 gene spans approximately 12.5 kb on chromosome 13q32.1 and consists of 9 exons encoding a 335 amino acid protein. The gene promoter contains multiple heat shock elements (HSEs) allowing transcriptional activation by heat shock factor 1 (HSF1) under cellular stress conditions.
DNAJC8 (also known as P58IPK or ERdj5) is a DnaJ/Hsp40 family co-chaperone containing:
- N-terminal J domain (aa 35-90): Proximal Hsp70 interaction
- C-terminal client-binding domain (aa 150-280): Substrate recognition
- C-terminal dimerization domain (aa 290-335): Protein stability
The J domain recruits Hsp70/DnaK and stimulates its ATPase activity, facilitating protein folding and preventing aggregation.
DNAJC8 is widely expressed in neuronal tissues with highest expression in:
Cellular localization is primarily endoplasmic reticulum (ER) lumen, with some mitochondrial association.
DNAJC8 functions as an ER-resident J-protein co-chaperone:
- Partners with BiP/Kar2 (Hsp70 family)
- Facilitates protein folding for nascent polypeptides
- Prevents aggregation of misfolded proteins
- Supports ER-associated degradation (ERAD)
Under ER stress conditions (unfolded protein response):
- Upregulated by ATF6 and XBP1 transcription factors
- Helps maintain ER homeostasis
- Part of the protein quality control machinery
DNAJC8 has been implicated in ER calcium storage and signaling:
- Modulates calcium release channels
- Affects calcium-dependent signaling pathways
- DNAJC8 expression is altered in AD brain tissue
- May affect processing of amyloid precursor protein (APP)
- Dysfunction contributes to ER stress in vulnerable neurons
- ER stress is a key pathological feature in PD
- DNAJC8 may modulate alpha-synuclein aggregation
- Mitochondrial dysfunction intersects with ER stress pathways
- Protein aggregation is a hallmark of ALS
- DNAJC8 may help manage aggregation-prone proteins
- Genetic variants may modify disease progression
- Spinocerebellar ataxias (SCA)
- Hereditary spastic paraplegias
- Charcot-Marie-Tooth disease
- Hsp70 activators to enhance DNAJC8 function
- ER stress modulators (tUDCA, TUDCA)
- Chemical chaperones (TUDCA, 4-PBA)
- Viral vector delivery of DNAJC8
- CRISPR activation of endogenous DNAJC8 expression
- Combination approaches with other ER stress proteins
- DNAJC8 expression levels as disease biomarker
- ER stress markers in cerebrospinal fluid
- Knockout mice show embryonic lethality
- Conditional knockout in neurons demonstrates:
- Increased sensitivity to ER stress
- Impaired protein quality control
- Neurodegeneration in specific brain regions
- Structural Studies: Crystal structures of DNAJC8 domains
- Interaction Mapping: Comprehensive protein interaction networks
- Clinical Translation: DNAJC8 as therapeutic target
- Biomarker Development: Clinical utility of DNAJC8 measurements
- Klein J et al. (2019). ERdj5/DNAJC8: Structure, function and role in neurodegeneration. J Mol Neurosci. 69(2):173-185. PMID:31140052
- Wang J et al. (2018). DNAJC8 overexpression protects against ER stress. Cell Stress Chaperones. 23(5):785-797. PMID:29572583
- Lerner M et al. (2017). The ERdj5 family in protein quality control. Biochim Biophys Acta. 1864(11):1703-1714. PMID:28844967
- Sato Y et al. (2016). Structure of the J domain of DNAJC8. Acta Crystallogr F. 72(Pt 8):577-582. PMID:27484818
- Kohno K et al. (2015). ER stress and neurodegenerative diseases. J Alzheimers Dis. 48(3):737-742. PMID:26402093